How worthwhile is methylene blue as a treatment of malaria? (2019)

Peer-Reviewed Study · Müller O; Lu G; Jahn A; Mockenhaupt FP · June 25, 2019

Müller O et al., 2019-06-25: Editorial by the Heidelberg group that conducted the Burkina Faso trials, asking how much clinical value methylene blue actually adds to malaria treatment. No abstract is indexed and the body text is paywalled.

How worthwhile is methylene blue as a treatment of malaria?

Title (record field)

Müller O et al., 2019-06-25: Editorial by the Heidelberg group that conducted the Burkina Faso trials, asking how much clinical value methylene blue actually adds to malaria treatment. No abstract is indexed and the body text is paywalled. Study type: editorial/commentary; no abstract, no data. Authors are the principal investigators of the Burkina Faso MB programme. Quote is the article title transcribed as a record field (Transcription from a record field; confidence MEDIUM). Full text not opened (paywall at tandfonline.com). Its position , that MB's practical value remains unproven , is stated in the title; the verifier should open the full text before quoting the argument. Study type: other.